Genetic products differentially expressed in tumors and use thereof | Patent Number 08551490

US 08551490 B2
Application Number13184719
Publication NumberUS 20120014948 A1
Pendency2 years, 2 months, 23 days
Filled DateJul 18, 2011
Priority DateMar 12, 2003
Publication DateJan 19, 2012
Expiration DateMar 12, 2023
Inventor/ApplicantsUgur Sahin
Michael Koslowski
Özlem Türeci
ExaminesHALVORSON, MARK
Art Unit1642
Technology Center1600
Assignments
Biontech Ag
Current
Ganymed Pharmaceuticals AgAstellas Pharma Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.